Having recently executed agreements to expand our service provision to new facilities in Adelaide, Brisbane, and Northern New South Wales, our geographic and customer base continues to expand, as does our investment in innovative IT solutions to enhance and support our Oncology clients.

Oncology facilities and practitioners recognise us as a market leader and the continued strengthening of our position in a growing marketplace like oncology augers well for the future.

We have compounding capabilities at three of our Oncology sites, but our Joint Venture agreement with Baxter Healthcare gives us access to TGA approved oncology products for the benefits of our customers.